pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Navigating rare disease research and treatment.

Genomics 105

Genomics Genome Research Medicine 105

pharmaphorum

DECEMBER 14, 2020

Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them. The post 5th Microbiome Movement – Drug Development Summit Europe 2021 appeared first on.

Development 52

Development Drugs Big Data Genomics 52

XTalks

APRIL 5, 2021

Bioinformaticians use a combination of mathematics, computer science and biology to help scientists make sense of the data gathered from research projects. The Human Genome Project could not have succeeded without the use of bioinformatics. This job furthers the field of biomedical research and supports drug development.

Bioinformatics 59

Bioinformatics Engineer Scientist Genomics 59

XTalks

JULY 24, 2024

Let’s explore how digital health is making significant strides in cancer care and research. RELATED: OncoHealth Expands Its Iris Platform for Digital Cancer Care Big Data and AI in Oncology Big data analytics is opening new avenues in cancer research.

Big Data 52

Big Data Clinical Trials Clinical Trials Life Science 52

pharmaphorum

SEPTEMBER 18, 2020

“AstraZeneca will have a strong base for considerable expansion, especially in research and development and geographical presence. Following AstraZeneca’s creation, the pharma company began to focus on five main areas of research – cardiovascular, gastrointestinal, respiratory, oncology and local and general anaesthesia.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

Delveinsight

FEBRUARY 17, 2021

The use is limited to advanced hospitals and research facilities and in some developed countries. The collected data and the genomic studies can play a crucial role in monitoring the symptoms and predicting potential diseases. . The safety of patients’ data is always a vital issue in the healthcare industry.

Doctors 52

Doctors Doctor Big Data Development 52

Pharma Marketing Network

OCTOBER 14, 2024

The rise of big data analytics, artificial intelligence, and machine learning has revolutionized drug discovery, development, and marketing. With advancements in genomics and biotechnology, there is a move towards tailoring treatments to individual patients based on their genetic makeup.

Marketing 52

Marketing Branding Big Data Drugs 52

The Pharma Data

JANUARY 4, 2021

Barber is an associate professor of biology and director of the Office of Student Research. Her research focuses on determining the role costimulatory domains play in enhancing chimeric T-cell activity and the creation and testing of the chPD1 receptor as a therapy for multiple types of cancer. Dr. Barber is a tumor immunologist.

In-Vivo 40

In-Vivo Development Immune Response Big Data 40

pharmaphorum

MARCH 16, 2021

International deep real-world evidence company Savana is on a mission to give health researchers the power to unlock the clinical value embedded within electronic health records (EHRs) using artificial intelligence (AI) and clinical Natural Language Processing (NLP) techniques. AI use in the pandemic.

Doctors 116

Doctors Doctor Life Science Clinical Research 116

pharmaphorum

FEBRUARY 17, 2022

Researchers discovered a highly virulent variant of HIV in the Netherlands that genetic sequence analysis suggests has been circulating since the 1990s. . Led by researchers from the University of Oxford ‘s Big Data Institute, the study underscores the significance of analysing viruses continually over time.

Genomics 98

Genomics Genome Genetics Genotype 98

The Pharma Data

JANUARY 17, 2021

There has never been a time when rapid, low burden access to patient-level data, at scale, was more urgent. rows of data. Syntegra has also engaged with the Federal Drug Administration (FDA) to evaluate the role of synthetic data in regulatory decisions, for COVID-19 and beyond. .

Life Science 52

Life Science Engineer Big Data Scientist 52